By 
The Power of 3-7-11 and the Grand Super Cycle: How We Saw the Bullish Turn in April 2025 Back on April 9, 2025, while World Indices were dropping sharply and global sentiment had turned overwhelmingly bearish, we published an article that challenged the fear-driven narrative. We explained why selling was not the right approach and […]
-
Biotech Surge: XBI Ends Correction and Rallies as Expected
Read MoreThe SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities and ongoing uncertainty. Analysts set a 12-month price target near $141.31. That suggests a 48% upside from current levels around $95. Technical indicators support this […]
-
Elliott Wave Blue Box Payoff: CADJPY Drops as Predicted
Read MoreIn this technical blog, we have looked at the past performance of CADJPY charts, in which the blue box area payoff & it drops as predicted.
-
Elliott Wave Insights for QQQ Nearing wave (3) Termination at 589
Read MoreNasdaq 100 Index ETF (QQQ) is looking to complete wave (3). This article and video look at the Elliott Wave path of the ETF and target higher
-
Alnylam (ALNY) Should Rally Into $479-$494 Before Correction Start
Read MoreAlnylam Pharmaceuticals Inc., (ALNY) discovers, develops & commercializes therapeutics based on ribonucleic acid interference. It comes under Healthcare – Biotech sector & trades as “ALNY” ticker at Nasdaq. ALNY is showing strong rally from April-2025 low in previous article & expect further rally once (4) pullback ends. It rallied more than 40% since last update […]